Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for NYSE stock GSK Glaxosmithkline Plc. Dated: 26 Nov 2024 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 34.23 and Closed at: 34.02, which is 0% of previous session's close. It moved within a range of 33.86 and 34.29
The session was a Bearish session with an average volume of 4194600, which is 0% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 33.73 and resistance for tomorrow is 34.16
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 33.82, 33.63 resistance for tomorrow's hourly charts is 34.25, 34.49
10 Day SMA for Glaxosmithkline Plc (GSK) is 33.81 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 35.08 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 37.56 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 39.48 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 40.68 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 35.08 and 200 DMA is at 40.68, while 50 DMA and 100 DMA are at 37.56 and 39.48 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 35.08 and 20 EMA is at 35.02
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Tue Nov | 34.02 | 35.08 | 35.02 |
| 26 Tue Nov | 34.02 | 35.23 | 35.13 |
| 25 Mon Nov | 34.15 | 35.43 | 35.25 |
| 22 Fri Nov | 33.96 | 35.62 | 35.37 |
| 21 Thu Nov | 33.70 | 35.8 | 35.52 |
| 20 Wed Nov | 33.35 | 36 | 35.71 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 37.56 and 50 EMA is at 37.07
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Tue Nov | 34.02 | 37.56 | 37.07 |
| 26 Tue Nov | 34.02 | 37.73 | 37.19 |
| 25 Mon Nov | 34.15 | 37.9 | 37.32 |
| 22 Fri Nov | 33.96 | 38.09 | 37.45 |
| 21 Thu Nov | 33.70 | 38.27 | 37.59 |
| 20 Wed Nov | 33.35 | 38.46 | 37.75 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 39.48 and 100 EMA is at 38.61
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Tue Nov | 34.02 | 39.48 | 38.61 |
| 26 Tue Nov | 34.02 | 39.53 | 38.7 |
| 25 Mon Nov | 34.15 | 39.57 | 38.79 |
| 22 Fri Nov | 33.96 | 39.62 | 38.88 |
| 21 Thu Nov | 33.70 | 39.67 | 38.98 |
| 20 Wed Nov | 33.35 | 39.72 | 39.09 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 40.68 and 200 EMA is at 39.27
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Tue Nov | 34.02 | 40.68 | 39.27 |
| 26 Tue Nov | 34.02 | 40.72 | 39.32 |
| 25 Mon Nov | 34.15 | 40.76 | 39.37 |
| 22 Fri Nov | 33.96 | 40.79 | 39.42 |
| 21 Thu Nov | 33.70 | 40.83 | 39.48 |
| 20 Wed Nov | 33.35 | 40.88 | 39.54 |
Zimmer Biomet has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Zimmer Biomet, about 10.93% more returns!
Smith Nephew has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Smith Nephew, about 8.29% more returns!
Arcus Biosciences has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Arcus Biosciences, about 10.65% more returns!
Novo Nordisk has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Novo Nordisk, about 2.25% more returns!
Msa Safety has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Msa Safety, about 12.77% more returns!
Merck Company has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Merck Company, about 6.77% more returns!
Medtronic Plc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Medtronic Plc, about 3.45% more returns!
Iqvia Holdings has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Iqvia Holdings, about 5.22% more returns!
Inspire Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Inspire Medical, about 4.42% more returns!
Herbalife Nutrition has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Herbalife Nutrition, about 12.09% more returns!
Glaxosmithkline Plc has performed better than Hca Healthcare in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Edwards Lifesciences has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 14.23% more returns!
Glaxosmithkline Plc has performed better than Enzo Biochem in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Emergent Biosolutions has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Emergent Biosolutions, about 18.16% more returns!
Charles River has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Charles River, about 18.18% more returns!
Civitas Solutions has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Civitas Solutions, about 11.53% more returns!
Glaxosmithkline Plc has performed better than Concord Medical in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Glaxosmithkline Plc in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 33.71 and Glaxosmithkline Plc GSK stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance